Search
for

    Sort by

    Research 751–780 of 1000+

    1. Imatinib-induced classical lichen planopilaris in blaschko-linear distribution leading to cicatricial alopecia Indian Dermatology Online Journal · 2021 · 2 citations
    2. Classic versus non‐classic: A survival Kit for life in the skin Pigment Cell & Melanoma Research · 2009 · 2 citations
    3. Clinical Snippets 2003 · 1 citations
    4. A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata Journal of health economics and outcomes research · 2026
    5. Unexpected Effect of Baricitinib Use: Observation of a Case of Hypertrichosis Indian Journal of Dermatology · 2026
    6. Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment Clinical and Translational Science · 2025
    7. Current best evidence in pigmentary dermatology Pigment International · 2024
    8. Dissecting the genetic variations associated with response to first-line chemotherapy in patients with small cell lung cancer: a retrospective cohort study Journal of Thoracic Disease · 2023
    9. 586 Interest of Silybum marianum extract, Manganese PCA and Lespedeza capitata extract in a new anti-hair loss serum to stimulate hair growth and prolong anagen phase Journal of Investigative Dermatology · 2022
    10. 721 Efficacy of silybum marianum extract, manganese PCA and lespedeza capitata extract on hair growth and anchorage in human dermal papilla cells 2022
    11. Immunohistochemical study assessing stem cell factor receptor C-kit in patients with alopecia Egyptian Journal of Dermatology and Venereology · 2020
    12. 적하수오 에탄올 추출물의 melanin 합성 촉진효과 생명과학회지 · 2017
    13. Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis Drug design, development and therapy · 2016 · 37 citations
    14. Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis Life · 2024 · 10 citations
    15. Sorafenib stimulates human skin type mast cell degranulation and maturation Journal of dermatological science · 2017 · 7 citations
    16. Quercetin rescues dihydrotestosterone-treated human dermal papilla cells via SHP2/AKT signaling to suppress autophagy and apoptosis Naunyn-Schmiedeberg s Archives of Pharmacology · 2024
    17. Transient Ca2+ entry by plasmalogen-mediated activation of receptor potential cation channel promotes AMPK activity Frontiers in molecular biosciences · 2022 · 3 citations
    18. Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database Dermatology and therapy · 2023 · 1 citations
    19. The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies Frontiers in pharmacology · 2022 · 37 citations
    20. Tofacitinib Treatment in Patients With Active COVID-19 Infection Curēus · 2021 · 2 citations
    21. Alopecia universalis successfully treated with tofacitinib Journal of the American Academy of Dermatology · 2017 · 2 citations
    22. Baricitinib as a treatment for myasthenia gravis: A case report Neuromuscular Disorders · 2024
    23. mTOR signaling in hair follicle and hair diseases: recent progress Frontiers in medicine · 2023
    24. Lady with Long Eyelashes…! International Journal of Trichology · 2022
    25. Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata JCI insight · 2021 · 42 citations
    26. Mimosine Dipeptide Enantiomsers: Improved Inhibitors against Melanogenesis and Cyclooxygenase Molecules · 2015 · 25 citations
    27. The potential impact of melanosomal pH and metabolism on melanoma Frontiers in Oncology · 2022 · 3 citations
    28. Photobiomodulation for Skin Pigmentation Disorders: A Dual-Function Treatment Photobiomodulation, photomedicine, and laser surgery · 2023 · 2 citations
    29. Canonical prolactin signaling and global mRNA expression in the skin of Holstein heifers carrying the SLICK1 allele of the prolactin receptor gene Journal of Dairy Science · 2025 · 1 citations
    30. First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors Journal of clinical oncology · 2011 · 505 citations